Shalini Sharp

2014 - Ultragenyx Pharmaceutical

In 2014, Shalini Sharp earned a total compensation of $512.1K as Chief Financial Officer and Executive Vice President at Ultragenyx Pharmaceutical, a 18% decrease compared to previous year.

Compensation breakdown

Bonus$30,000
Non-Equity Incentive Plan$117,563
Salary$350,000
Other$14,500
Total$512,063

Sharp received $350K in salary, accounting for 68% of the total pay in 2014.

Sharp also received $30K in bonus, $117.6K in non-equity incentive plan and $14.5K in other compensation.

Rankings

In 2014, Shalini Sharp's compensation ranked 10,190th out of 13,032 executives tracked by ExecPay. In other words, Sharp earned more than 21.8% of executives.

ClassificationRankingPercentile
All
10,190
out of 13,032
22nd
Division
Manufacturing
3,869
out of 4,965
22nd
Major group
Chemicals And Allied Products
1,328
out of 1,690
21st
Industry group
Drugs
1,061
out of 1,369
23rd
Industry
Pharmaceutical Preparations
814
out of 1,042
22nd
Source: SEC filing on April 28, 2017.

Sharp's colleagues

We found three more compensation records of executives who worked with Shalini Sharp at Ultragenyx Pharmaceutical in 2014.

2014

Sunil Agarwal

Ultragenyx Pharmaceutical

Chief Medical Officer

2014

Emil Kakkis

Ultragenyx Pharmaceutical

Chief Executive Officer

2014

Thomas Kassberg

Ultragenyx Pharmaceutical

Senior Vice President and Chief Business Officer

News

You may also like